MTF Biologics and Kolosis BIO Launch Two New Allografts to Advance Cardiac Surgery

ATLAS ™ Sternal Repair Matrix is intended for challenging sternal fusion cases and IKON ™ Allogenic Matrix assists with soft tissue repair in high-risk patients EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), … [Read more…]

AI in Ultrasound Imaging Market Research 2025-2035 Featuring GE, Siemens Healthineers, Fujifilm, Canon Medical, EchoNous, Samsung, Butterfly Network, NovaSignal, Esaote, Exo AI, and Clarius – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global AI in Ultrasound Imaging Market: Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. Ultrasound imaging is a medical diagnostic technique that uses high-frequency sound waves to produce real-time images of the inside of the body. It is widely used in medical fields to visualize tissues, organs, and developing foetuses, … [Read more…]

Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions Conference

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41st Annual Strategic Decisions Conference on Wednesday, May 28, 2025. The company will take part in a fireside chat beginning at 3:30 p.m. ET. Investors and the general public are invited to listen to the session by visiting … [Read more…]

MarinHealth Launches Comprehensive Cardiothoracic Surgery Program as Part of Its Heart and Vascular Institute

Bringing World-Class Expertise and Exceptional Outcomes to the North Bay and Beyond GREENBRAE, Calif.–(BUSINESS WIRE)–#Marin—MarinHealth is proud to announce the launch of its new Cardiothoracic Surgery Program, as part of the MarinHealth Heart and Vascular Institute, to provide advanced surgical care for complex heart and thoracic conditions. Based at MarinHealth Medical Center, this program brings … [Read more…]

PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial

Deupirfenidone 825 mg TID slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF) to the range expected of healthy older adults over 6 months; new, preliminary open-label extension data support durability of this treatment effect over at least 52 weeks Deupirfenidone 825 mg TID demonstrated a statistically significant benefit compared to placebo in … [Read more…]

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. MOUNT LAUREL, N.J.–(BUSINESS WIRE)–CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program … [Read more…]

City of Hope Urges Bold Action to Address Rise in Cancer Among Younger Women

With Cancer Rates in Women Under 50 now 82% Higher Than Men, Leading National Cancer Research and Treatment Organization Calls for Age-Specific Research, Expanded Risk Assessments, and Lifetime Survivorship Support LOS ANGELES–(BUSINESS WIRE)–City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical … [Read more…]

Forvis Mazars Healthcare Survey: Solid Growth Plans Will Be Tempered by Workforce, Regulatory Challenges

Report focuses on major themes of aligned growth, financial discipline, regulatory excellence, strategic agility, and talent optimization NEW YORK–(BUSINESS WIRE)–Healthcare executives are optimistic about future growth and financial performance, but they have concerns about regulatory and reimbursement restructuring as well as talent and workforce challenges, according to the Mindsets 2025 Healthcare Executive Leadership Report from … [Read more…]

Mirion Technologies Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2030

ATLANTA–(BUSINESS WIRE)–Mirion Technologies, Inc. (“Mirion”) (NYSE: MIR), today announced its intent to offer $300.0 million aggregate principal amount of Convertible Senior Notes due 2030 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities … [Read more…]

Dassault Systèmes and the FondaMental Foundation Launch a Sovereign and Secured Nationwide Health Data Warehouse in France Dedicated to Psychiatry

High performance, sovereign and scalable cloud environment meets the highest standards for protecting sensitive health data Dassault Systèmes, through its OUTSCALE brand, addresses growing needs for health data security for processing and analysis Collaboration aligns with France’s 2025 public health priorities to structure and leverage complex clinical data within a sovereign and highly secure framework … [Read more…]